| (Values in U.S. Thousands) | Jun, 2022 | Mar, 2022 | Dec, 2021 | Sep, 2021 | Jun, 2021 |
| Sales | 2,630 | 4,790 | 3,040 | 4,080 | 5,890 |
| Sales Growth | -45.09% | +57.57% | -25.49% | -30.73% | +57.49% |
| Net Income | -116,470 | -72,120 | -78,140 | -98,230 | -100,830 |
| Net Income Growth | -61.49% | +7.70% | +20.45% | +2.58% | -19.20% |
Zymergen Inc
(ZY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Zymergen Inc. is a biofacturing company. It design, develop and manufacture bio-based breakthrough products. Zymergen Inc. is based in EMERYVILLE, Calif.
Fiscal Year End Date: 12/31